Navigation Links
Ripple Science Announces Initiatives for Clinical Research Teams During COVID
Date:4/22/2020

Ripple Science today announced new initiatives to help clinical researchers continue their work through COVID-19. Many clinical trial teams are working remotely and have paused patient visits, forcing teams to do more of their work online. Ripple Science wants to help researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six months of access to Ripple free of charge.

Ripple is a web-based platform designed for clinical research teams who want a secure and streamlined way to recruit, manage, and retain patients for trials. Ripple is a purpose-built CRM and project manager which organizes clinical trial recruiting and research efforts, leading to valuable time and cost savings. Debi Gross, Community Outreach Director for Stony Brook University’s autism initiative, stated, “The fact that Ripple is web-based is a game-changer for us… The time between when participants contact us to enrolling them in a study seems a lot shorter and quicker.”

Peter Falzon, President and CEO of Ripple Science, commented, "We are committed to supporting research teams to work remotely and communicate with patients differently in response to COVID-19. Our customers have been telling us what they need and how Ripple helps, and we are responding to their needs by accelerating feature updates and expanding access.”

In the upcoming weeks, Ripple Science will release features aligned to even better support the initiatives of researchers working in this new paradigm.

About Ripple Science: Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants faster and reduces patient loss to poor follow-up. Ripple Science’s flagship product, Ripple, is used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.

Read the full story at https://www.prweb.com/releases/ripple_science_announces_initiatives_for_clinical_research_teams_during_covid/prweb17062343.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. NeuroFlow Awarded $750K from the National Science Foundation for SBIR Phase II
2. P2 Science and Bedoukian Research Announce Pheromones Collaboration
3. RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the Clinic
4. Major Infant Health Collaboration Announced by APC Microbiome Ireland with DuPont Nutrition & Biosciences
5. Park Systems Opens Park Nanoscience Center Equipped with Cleanroom and Line of Academic and Industrial Tools
6. Cerebyte Launches Neuroscience of Transformational Leadership Workshops
7. With the Industry Booming, Slone Partners Celebrates 20 Years as a Leader in Life Sciences and Biotech Executive Search
8. Vuja De Sciences Announces the Appointment of Two New Board Members
9. ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2020 Cohort of Life Science Startups
10. Vici Health Sciences Expands Staff and Footprint in Maryland to Meet Customer Demands
11. Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... solutions in complex indoor environments, announced today that Derek Fournier has been appointed ... of Chairman of the Board, effective immediately. , “DeCurtis Corporation has been ...
(Date:6/11/2020)... ... 2020 , ... Greffex, a leading genetic engineering company, with ... viral vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to ... most successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments ...
(Date:6/2/2020)... SPRINGFIELD, Ill. (PRWEB) , ... June 01, 2020 ... ... a helping hand to companies and encourage positive change in the world, enterprise ... the coronavirus pandemic. , With more people working from home during self-quarantines and ...
(Date:5/26/2020)... ... 26, 2020 , ... Brilliant , the leading smart home control and ... openers, announce a new integration to bring more convenience, simplicity, and security to the ... Aladdin Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile ...
Breaking Biology Technology:
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled ... accelerated Point of Care Testing solutions (POCT). Check local listings for more info. , ... medical offices and are shipped to labs throughout the country. Results are then available ...
(Date:6/23/2020)... (PRWEB) , ... June 23, ... ... provider of gene-to-protein and monoclonal antibody development services, today announced that the ... products and services to the pharmaceutical, diagnostics, and research industries. The decision ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
Breaking Biology News(10 mins):